HIV DART 2020 Electronic Poster Session
Welcome to the e-poster portal for HIV & Respi DART 2020. All accepted abstracts are listed below for your viewing.
Please click on each abstract title to review the poster presentation which will open in a pop-up window.
If you have any questions regarding the presented data, please use the contact information provided for each presenting author to contact them.
The complete abstract booklet for HIV & Respi DART 2020 can be found here.
Characterization of tissue resident myeloid cells in the liver and lung of SIV-infected rhesus macaques.
Poster Number: 1001
Category: HIV DART
Presenter: Julien Clain, Université Laval, Canada
An Approach to Improve Diversity and Inclusion in Clinical Trials: The DEFINE Trial (D/C/F/TAF Evaluated as a Fixed Dose Combination Regimen in Participants Switching from an Integrase Inhibitor who have Experienced Rapid Weight Gain)
Poster Number: 1002
Category: HIV DART
Presenter: Keith Dunn, Janssen Scientific Affairs, LLC, Titusville, NJ, USA
Contact: kdunn1@its.jnj.com
Chimigen® HIV: A Novel Dendritic Cell Receptor-Targeted Multi-Antigen HIV Vaccine
Poster Number: 1003
Category: HIV DART
Presenter: Rajan George, Akshaya Bio Inc., Canada
Contact: rajan.george@akshayabio.com
Weight changes associated with patients with high BMI after initiation or switching ART regimen
Poster Number: 1004
Category: HIV DART
Presenter: Jennifer Kuretski, Midway Specialty Care Center, USA
Contact: jkuretski@midwaycare.org
A cross-sectional study to assess the metabolic syndrome prevalence and cardiovascular disease risk factors in HIV-positive men
Poster Number: 1005
Category: HIV DART
Presenter: Win-Long Lu, Institute of Medicine, Chung Shan Medical University, Taichung city, Taiwan
Contact: winlonglu@gmail.com
Long-term SHIV Suppression Using AAV Delivery of Monoclonal Antibodies
Poster Number: 1006 (Oral presentation)
Category: HIV DART
Presenter: Jose Martinez-Navio, University of Miami - Miller School of Medicine, USA
Contact: martinez-navio@med.miami.edu
Metabolically Stable ω-Functionalized Lipid Prodrugs of Tenofovir Have the Potential to Serve as Safer, Long-Acting Antiretrovirals for the Treatment of HIV.
Poster Number: 1007
Category: HIV DART
Presenter: Nicole Pribut, Emory University, USA
Contact: nicole.pribut@emory.edu
Integrase drug resistance mutations in proviral DNA of HIV-1 Individuals in Puerto Rico
Poster Number: 1008
Category: HIV DART
Presenter: Grissell Tirado, Ponce Health Sciences University, USA
Contact: gtirado@psm.edu
First evaluation of Next-Generation Sequencing and Sanger Sequencing for the detection of HIV1 drug resistance mutations using CE-IVD assays and Software
Poster Number: 1009
Category: HIV DART
Presenter: Mohamed Sofiane, ABL FRANCE, France
Contact: s.mohamed@ablsa.com